The present studies also add OCTN2 and ATB0,+ to this list as potential molecules on colon cancer cells to target nanoparticles with modification of their surface with L-carnitine as the ligand for both transporters. This evidence concerns the gene SLC22A5 and malignant colon neoplasm.